FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 103 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,442,000 | +115.2% | 64,800 | -2.8% | 0.03% | +100.0% |
| Q4 2020 | $1,135,000 | +415.9% | 66,700 | +42.5% | 0.01% | +366.7% |
| Q3 2020 | $220,000 | +1275.0% | 46,800 | +1772.0% | 0.00% | – |
| Q2 2020 | $16,000 | +166.7% | 2,500 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | +20.0% | 2,500 | +150.0% | 0.00% | – |
| Q4 2019 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | -99.5% | 1,000 | -94.3% | 0.00% | -100.0% |
| Q4 2016 | $872,000 | -69.7% | 17,400 | -68.2% | 0.01% | -68.2% |
| Q3 2016 | $2,876,000 | +79.3% | 54,800 | +41.2% | 0.02% | +57.1% |
| Q2 2016 | $1,604,000 | – | 38,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |